Memorial Sloan Kettering ’ s Chief Executive Resigns From Merck ’ s Board of Directors

Under scrutiny for the hospital ’ s industry ties and compensation, Dr. Craig B. Thompson stepped down from two company boards.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Thompson, Craig B Memorial Sloan-Kettering Cancer Center Executive Compensation Boards of Directors Conflicts of Interest Merck & Company Inc Charles River Laboratories Source Type: news